The Effect of Whole Body Vibration (WBV) on Spasticity in Poststroke Hemiplegia
WBV
1 other identifier
interventional
48
1 country
1
Brief Summary
The primary purpose of this study is to show whether WBV application has antispastic effect. The secondary aim is to demonstrate whether WBV has neuromodulatory activity on increased stretch reflex and motor neuron activity, which is the basis of the pathophysiology of spasticity.Hypotheses of this study:Whole body vibration in poststroke hemiplegia reduces ankle plantar flexion spasticity.
- 1.WBV ; reduces plantar flexor spasticity after stroke
- 2.WBV decreases poststroke spasticity, by decreasing increased stretch reflex and motor neuron activity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2019
CompletedFirst Posted
Study publicly available on registry
April 16, 2019
CompletedStudy Start
First participant enrolled
August 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2020
CompletedJanuary 13, 2022
December 1, 2021
7 months
April 11, 2019
December 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
spasticity-torque
Spasticity will be measured as a torque. The unit is Nm
4 weeks
spasiticity-modified Ashworth scale
The spasticity degree of the plantar flexors will be evaluated by using a subjective assessment method (modified Ashworth scale-MAS)
4 weeks
spasticity-homosynaptic post-activation depression (HPAD)
Homosynaptic post-activation depression is a presynaptic mechanism regulating the excitability of the stretch reflex. Decreased presynaptic inhibition and homosynaptic depression are also thought to play a role in the pathophysiology of spasticity. The higher HPAD, the lower spasticity
4 weeks
Motor neuron activity-Hmax / Mmax ratio
Hmax / Mmax ratio defines motor neuron activity. The higher this ratio, the higher the activity of motor neuron pool
4 weeks
Study Arms (2)
whole body vibration
ACTIVE COMPARATORWBV(whole body vibration) will be applied to interventional group for 4 weeks, 3 days a week, a total of 12 sessions while standing upright with the WBV powerplate pro5 device.(Vibration frequency: 30Hz, amplitude: 2.2 mm at progressively increasing duration)
Sham whole body vibration
SHAM COMPARATORThe sham WBV will be applied to the Control group. A WBV device with 99.5% weakened amplitude will be used for sham WBV. (Application duration of the sham WBV will be same as WBV in the treatment group ).
Interventions
The Sham control group will have WBV the same time,in the same position with the same frequency but 99.5% weakened amplitude.
The intervention group will have WBV(frequency:30Hz,amplitude:2,2mm,at upright position
Eligibility Criteria
You may qualify if:
- Ischemic / hemorrhagic poststroke hemiplegia aged 18-90 years,
- Stroke time ≥1 months,
- Ankle plantar flexor spasticity MAS ≥1,
- Brunnstrom stage ≥3 for lower extremity,
- Patients who were standing for more than five minutes and had a static balance
You may not qualify if:
- Cardiac disorder (rhythm / conduction disorder, cardiac pacemaker, ischemic heart disease)
- Lower extremity fracture,
- Findings or suspicion of active deep vein thrombosis,
- A history of deep vein thrombosis and pulmonary embolism,
- Orthostatic hypotension
- Resistant hypertension,
- Peripheral nerve lesions such as polyneuropathy, radiculopathy
- Active inflammatory, rheumatologic or infectious disease,
- Ankle,knee or hip joint contracture,
- Presence of panic attacks,
- Patients with dizziness and balance problems,
- Patients with not intact skin surface to connect electrodes
- Patients with communication problems: aphasia, major depression
- Epilepsy
- Patients who received botulinum A toxin in the last 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Physical Medicine Rehabilitation Training and Research Hospital Istanbul, Turkey
Istanbul, Turkey (Türkiye)
Related Publications (5)
Chan KS, Liu CW, Chen TW, Weng MC, Huang MH, Chen CH. Effects of a single session of whole body vibration on ankle plantarflexion spasticity and gait performance in patients with chronic stroke: a randomized controlled trial. Clin Rehabil. 2012 Dec;26(12):1087-95. doi: 10.1177/0269215512446314. Epub 2012 Oct 3.
PMID: 23035004BACKGROUNDPang MY, Lau RW, Yip SP. The effects of whole-body vibration therapy on bone turnover, muscle strength, motor function, and spasticity in chronic stroke: a randomized controlled trial. Eur J Phys Rehabil Med. 2013 Aug;49(4):439-50. Epub 2013 Mar 13.
PMID: 23486302BACKGROUNDMiyara K, Matsumoto S, Uema T, Noma T, Ikeda K, Ohwatashi A, Kiyama R, Shimodozono M. Effect of whole body vibration on spasticity in hemiplegic legs of patients with stroke. Top Stroke Rehabil. 2018 Mar;25(2):90-95. doi: 10.1080/10749357.2017.1389055. Epub 2017 Oct 16.
PMID: 29032720BACKGROUNDBrogardh C, Flansbjer UB, Lexell J. No specific effect of whole-body vibration training in chronic stroke: a double-blind randomized controlled study. Arch Phys Med Rehabil. 2012 Feb;93(2):253-8. doi: 10.1016/j.apmr.2011.09.005.
PMID: 22289234BACKGROUNDAlp A, Efe B, Adali M, Bilgic A, Demir Ture S, Coskun S, Karabulut M, Ertem U, Gunay SM. The Impact of Whole Body Vibration Therapy on Spasticity and Disability of the Patients with Poststroke Hemiplegia. Rehabil Res Pract. 2018 May 2;2018:8637573. doi: 10.1155/2018/8637573. eCollection 2018.
PMID: 30225145BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ayşenur Bardak, Prof
Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Patients will be blind to treatment
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 11, 2019
First Posted
April 16, 2019
Study Start
August 1, 2019
Primary Completion
March 1, 2020
Study Completion
August 1, 2020
Last Updated
January 13, 2022
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share